Long-term treatment of bipolar disorder with lamotrigine

Journal of Clinical Psychiatry

Volumn 63, Issue SUPPL. 10, 2002, Pages 18-22

  Calabrese, Joseph R ^a   Shelton, Melvin D ^a   Rapport, Daniel J ^a   Kimmel, Susan E ^a   Elhaj, Omar ^a  

^a Mood Disorders Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM;

CHRONIC DISEASE; DISEASE SEVERITY; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MOOD; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; RECURRENT DISEASE; REVIEW; SIDE EFFECT; STEVENS JOHNSON SYNDROME; SUICIDE; SURVIVAL; TOXIC EPIDERMAL NECROLYSIS; WEIGHT GAIN;

ANTICONVULSANTS; BIPOLAR DISORDER; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; HUMANS; LONG-TERM CARE; LONGITUDINAL STUDIES; PLACEBOS; RECURRENCE; RESEARCH DESIGN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TRIAZINES;

EID: 0036394128     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Ketter TA, Calabrese JR. Stabilization of mood from below versus above the baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry 2002;63:146-151
2. Zomberg GL, Pope HG. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993;13:397-408
3. Baldessarini RJ, Tondo L, Floris G, et al. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J Affect Disord 2000;61:13-22
4. Calabrese JR, Shelton MD, Bowden CL, et al. Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry 2001;62(suppl 14):34-41
5. Keller MB, Lavori PW, Coryell W, et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986;255:3138-3142
6. Vojta C, Kinosian B, Glick H, et al. Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry 2000;57:481-489
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington. DC: American Psychiatric Association; 1994
8. Bowden CL, Calabrese JR, McElroy SL, et al. Divalproex versus lithium for bipolar I disorder. Arch Gen Psychiatry 2000;57:481-489
9. Prien RF, Klett CJ, Caffey EM. Lithium prophylaxis in recurrent affective illness. Am J Psychiatry 1974;131:198-203
10. Prien RF, Kupfer DJ, Mansky PA, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar disorders: report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984;41:1095-1104
11. Prien RF, Caffey EM Jr, Klett CJ. Prophylactic efficacy of lithium carbonate in manic-depressive illness: report of the Veteran's Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 1973;28:337-341
12. Shapiro DR, Quitkin FM, Fleiss JL. Response to maintenance therapy in bipolar illness: effect of index episode. Arch Gen Psychiatry 1989;46:401-405
13. Baastrup PC, Poulsen JC, Schou M, et al. Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970;2:326-330
14. Coppen A, Noguera R, Bailey J, et al. Prophylactic lithium in affective disorders: controlled trial. Lancet 1971;2:275-279
15. Cundall RL, Brooks PW, Murray LG. A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 1972;2:308-311
16. Melia PI. Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 1970;116:621-624
17. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88
18. Ghaemi SN, Sachs GS, Chiou AM, et al. Is bipolar disorder still underdiagnosed? are antidepressants overutilized? J Affect Disord 1999;52:135-144
19. Nemeroff CB, Evans DL, Gyulai L, et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001;158:906-912
20. Smith D, Chadwick D, Baker G, et al. Seizure severity and the quality of life. Epilepsia 1993;34(suppl 5):31-35
21. Calabrese JR, Sullivan JR, Bowden CL, et al. Rash in lamothgine mood disorder multicenter trials: clinical relevance and management. J Clin Psychiatry. In press
22. Berlant JL. Case report of synergistic response of rapid cycling bipolar disorder to lamotrigine, risperidone, and verapamil. In: Abstracts of the 2nd International Conference on Bipolar Disorder; 1997; Pittsburgh, Pa: Abstract 8
23. Fatemi SH, Rapport DJ, Calabrese JR, et al. Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 1997;58:522-527
24. Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997;72:145-148
25. Sporn J, Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997;17:185-189
26. Bowden CL, Ascher JA, Calabrese JR, et al. Lamotrigine: evidence for mood stabilization in bipolar I depression. In: New Research Abstracts of the 2001 Annual Meeting of the American Psychiatric Association; May 8, 2001; New Orleans, La. Abstract NR380:103
27. Calabrese JR, Bowden CL, DeVeaugh-Geiss J, et al. Lamotrigine demonstrates long-term mood stabilization in manic patients. In: New Research Abstracts of the 2001 154th Annual Meeting of the American Psychiatric Association; May 8, 2001; New Orleans, La. Abstract NR403:110